This compound is an Fmoc-protected amino acid derivative designed for use in solid-phase peptide synthesis. It features a 2,4-dimethoxybenzyl protecting group on the amino nitrogen, making it suitable for selective deprotection strategies in research-scale peptide assembly.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 166881-42-1
N-Fmoc-N-(2,4,6-trimethoxybenzyl)glycine
Pharmaceutical intermediate for peptide synthesis
Fmoc-L-Propargylglycine
Fmoc-protected amino acid for peptide synthesis
3-((Acetamidomethyl)sulfanyl)-N-(((9H-fluoren-9-yl)methoxy)carbonyl)-L-valine
Fmoc-protected amino acid for peptide synthesis
Fmoc-Ala-OH H2O
Fmoc-protected amino acid for peptide synthesis
Fmoc-Gly-OH
Fmoc-protected amino acid for peptide synthesis
Finasteride Impurity
Pharmaceutical intermediate for finasteride
N-Methyl-4-nitrophenethylamine hydrochloride
Pharmaceutical intermediate
1H-Indole-6-carboxylic acid
pharmaceutical intermediate
2-[(2,4-dimethoxyphenyl)methyl-(9H-fluoren-9-ylmethoxycarbonyl)amino]acetic acid
UIDQSTVPYKMCEY-UHFFFAOYSA-N
COC1=CC(=C(C=C1)CN(CC(=O)O)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)OC